Denis Fouque

1992–2025 年に発表

171
論文数
25,759
被引用数
86
h 指数
157
i10 指数

被引用数

Denis Fouque の年別被引用数1990 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 2 件1996 年: 被引用 6 件1997 年: 被引用 5 件1998 年: 被引用 3 件1999 年: 被引用 12 件2000 年: 被引用 10 件2001 年: 被引用 16 件2002 年: 被引用 12 件2003 年: 被引用 19 件2004 年: 被引用 18 件2005 年: 被引用 33 件2006 年: 被引用 27 件2007 年: 被引用 56 件2008 年: 被引用 50 件2009 年: 被引用 82 件2010 年: 被引用 74 件2011 年: 被引用 82 件2012 年: 被引用 89 件2013 年: 被引用 136 件2014 年: 被引用 123 件2015 年: 被引用 110 件2016 年: 被引用 167 件2017 年: 被引用 189 件2018 年: 被引用 187 件2019 年: 被引用 687 件2020 年: 被引用 867 件2021 年: 被引用 1,016 件2022 年: 被引用 792 件2023 年: 被引用 630 件2024 年: 被引用 1,032 件2025 年: 被引用 537 件2026 年: 被引用 9 件1991〜1992 年は被引用が無いため表示していません1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,678 件、この内訳の 16.1%中国: 引用元論文 795 件、この内訳の 7.6%イタリア: 引用元論文 692 件、この内訳の 6.7%イギリス: 引用元論文 689 件、この内訳の 6.6%フランス: 引用元論文 579 件、この内訳の 5.6%ドイツ: 引用元論文 485 件、この内訳の 4.7%スペイン: 引用元論文 421 件、この内訳の 4%オランダ: 引用元論文 416 件、この内訳の 4%カナダ: 引用元論文 345 件、この内訳の 3.3%オーストラリア: 引用元論文 331 件、この内訳の 3.2%スウェーデン: 引用元論文 315 件、この内訳の 3%日本: 引用元論文 310 件、この内訳の 3%
0%16.1%その他 32.2%

分野

  • Medicine73.4%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Immunology and Microbiology6.5%
  • Health Professions2.9%
  • Nursing2.7%
  • Environmental Science0.9%
  • その他3.2%

トピック

  • Dialysis and Renal Disease Management12.8%
  • Chronic Kidney Disease and Diabetes6.2%
  • Nutrition and Health in Aging3.8%
  • Parathyroid Disorders and Treatments3.6%
  • Acute Kidney Injury Research2.5%
  • Complement system in diseases2.3%
  • その他68.8%

共著者

全論文

検索で開く
  1. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update

    著者: , , , , , , , , , , , , , , - American Journal of Kidney Diseases 2020 被引用: 1,799

  2. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marlies Ostermann, Lesley Rees, Pierre Ronco, Franz Schaefer, Jennifer St. Clair Russell, Caroline Vinck, Stephen B. Walsh, Daniel E. Weiner, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer­ - Kidney International 2020 被引用: 713

  3. Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lothar Bernd Zimmerhackl, Tim Goodship, Chantal Loirat - New England Journal of Medicine 2013 被引用: 1,561

  4. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

    著者: , , , , , , , , , , , , , , , , - Kidney International 2007 被引用: 1,954

  5. Plant-based diets to manage the risks and complications of chronic kidney disease

    著者: , , , , , , , , , , , , , , - Nature Reviews Nephrology 2020 被引用: 305

  6. The systemic nature of CKD

    著者: , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2017 被引用: 438

  7. Nutritional Management of Chronic Kidney Disease

    著者: , - New England Journal of Medicine 2017 被引用: 615

  8. Nutritional status and the risk of malnutrition in older adults with chronic kidney disease – implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN

    著者: , , , , , , , , , , , , - Clinical Nutrition 2023 被引用: 134

  9. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism

    著者: , , , , , , , , , , , - Kidney International 2013 被引用: 706

  10. Kidney cachexia or protein‐energy wasting in chronic kidney disease: facts and numbers

    著者: , , - Journal of Cachexia Sarcopenia and Muscle 2019 被引用: 228

  11. The role of phosphate in kidney disease

    著者: , , , , , , - Nature Reviews Nephrology 2016 被引用: 251

  12. p-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD

    著者: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2012 被引用: 266

  13. Probiotics and chronic kidney disease

    著者: , , - Kidney International 2015 被引用: 263

  14. Low protein diets for non-diabetic adults with chronic kidney disease

    著者: , , - Cochrane Database of Systematic Reviews 2018 被引用: 126

  15. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dimitrios Goumenos, Ayşe Tuğba Kartal, Laila‐Yasmin Mani, Hans-Peter Marti, Christopher Mayer, Rikke Nielsen, Vesna Pešić, Merita Rroji, Giorgos K. Sakkas, Goce Spasovski, Kate Stevens, Evgueniy Vazelov, Davide Viggiano, Lefteris C. Zacharia, Ana Carina Ferreira, Jolanta Malyszko, Ewout J. Hoorn, Andreja Figurek, Robert J. Unwin, Carsten A. Wagner, Christoph Wanner, Annette Bruchfeld, Marion Pépin, Andrzej Więcek, Dorothea Nitsch, Ivo Fridolin, Gaye Hafez, María José Soler Romeo, Michelangela Barbieri, Bojan Batinić, Laura Carrasco, Sol Carriazo, Ron T. Gansevoort, Gianvito Martino, Francesco Mattace‐Raso, Ionuţ Nistor, Alberto Ortíz, Giuseppe Paolisso, Daiva Rastenytė, Gabriel Ştefan, Gioacchino Tedeschi, Ziad A. Massy, Boris Bikbov, Karlhans Endlich, Olivier Godefroy, Jean‐Marc Chillon, Anastassia Kossioni, Justina Kurganaite, Norberto Perico, Giuseppe Remuzzi, Tomasz Grodzicki, Francesco Trepiccione, Carmine Zoccali, Mustafa Arıcı, Peter J. Blankestijn, Kai‐Uwe Eckardt, Danilo Fliser, Eugenio Gutiérrez Jiménez, Maximilian König, Ivan Rychlík, Michela Deleidi, György Reusz - Nephrology Dialysis Transplantation 2021 被引用: 90

  16. Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial

    著者: , , , , , , , , , - Journal of Renal Nutrition 2017 被引用: 149

  17. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study

    著者: , , , , , , , , , , , - Clinical Nutrition 2020 被引用: 107

  18. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

    著者: , , , , , , , , , , , , - The Lancet 2014 被引用: 434

  19. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2020 被引用: 377

  20. Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells

    著者: , , , - Toxins 2020 被引用: 157

  21. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy

    著者: , , , , , , , - Nephrology Dialysis Transplantation 2012 被引用: 569

  22. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    著者: , , , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2019 被引用: 204

  23. Towards a multidisciplinary approach to understand and manage obesity and related diseases

    著者: , , , , , , , , , , , , , , , , , , - Clinical Nutrition 2016 被引用: 213

  24. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France

    著者: , , , , , , , , , , , , , , - American Journal of Kidney Diseases 2019 被引用: 116